AZN AZN
P/E
--
Forward P/E
--
Price/Sales
--
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Healthcare Movers: Key Drug Approvals and Corporate Updates
The healthcare sector saw key regulatory and corporate news this week. AstraZeneca received U.S. FDA approval for Baxfendy, a first-in-class drug for...
AstraZeneca PLC Q1 2026 Earnings Preview: What Analysts Expect on April 29, 2026
AstraZeneca is projected to report Q1 2026 revenue of $14.98 billion and core EPS of $2.57, with its current stock price of $189.71 trading below the average...